Patients with a positive baseline serum pgRNA had a worse prognosis and a higher cumulative recurrence rate after systemic treatment(Figure 1)
But emerging evidence suggests that non-steroidal anti-inflammatory drugs (NSAIDs) may offer a solution
Recent studies in kidney transplant recipients with PTDM found that empagliflozin improves glycemic control and reduces body weight compared to the placebo group
The theoretical benefits of glycine, including muscle preservation and metabolic support, could contribute to better long-term body composition outcomes, but this has not been confirmed in controlled studies specific to this combination
Contraindications or require Caution: individuals who are pregnant or breastfeeding, have a history of cancer, or have pre-existing liver or kidney conditions
Without enough of it, the brains ability to regulate inflammation, detoxify, and repair itself can sufferleading to a noticeable dip in mental clarity, alertness, and overall cognitive performance